Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Neuraminidase inhibitor holds promise for flu

Feb. 14, 1997

Milestone achieved in Microcide/Pfizer collaboration

Feb. 10, 1997

Antifungal agent revealed by Bayer

Feb. 10, 1997

Japanese researchers describe triazole antifungals

Feb. 7, 1997

Rockefeller University discloses antibiotic peptides

Feb. 7, 1997

Another approval for first-line Abelcet

Feb. 6, 1997

Magainin analogues reported by Scripps

Feb. 6, 1997

Cephems in development at Meiji Seika

Feb. 6, 1997

Takeda discloses novel cephems

Feb. 5, 1997

U.S. patent for Tularik drug discovery assays

Feb. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...